These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8324045)

  • 21. Early supernatants of mitogen-stimulated mononuclear cells promote long-term IL-2-dependent growth of human T lymphocytes.
    Siwicki JK; Steffen JA
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):109-17. PubMed ID: 8915514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of human lymphocyte mitogen responsiveness and interleukin-2 production by polymorphonuclear leukocytes.
    Lyte M
    J Clin Lab Immunol; 1990 Jun; 32(2):91-5. PubMed ID: 1967045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of skin adherence, penetration and tissue necrosis production by Haemophilus ducreyi, the causative agent of chancroid.
    Abeck D; Korting HC
    Acta Derm Venereol Suppl (Stockh); 1992; 174():1-20. PubMed ID: 1636361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isoprinosine potentiation of human peripheral blood mononuclear cell response to mitogens: kinetics and effect on expression of the IL-2 receptor and the activity of interleukin 2.
    Lomnitzer R
    J Clin Lab Immunol; 1988 Oct; 27(2):91-6. PubMed ID: 2469797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous production of a suppressor factor by a human macrophage-like cell line U937. II. Suppression of antigen- and mitogen-induced blastogenesis, IL 2 production and IL 2 receptor expression in T lymphocytes.
    Fujiwara H; Toossi Z; Ohnishi K; Edmonds K; Ellner JJ
    J Immunol; 1987 Jan; 138(1):197-203. PubMed ID: 3097146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depressed PMNC blastogenic response in patients with cancer of the head and neck: a study of IL-2 production, IL-2 consumption, and IL-2 receptor expression.
    Eskinazi DP; Perna JJ; Ershow AG; Mihail RC
    Laryngoscope; 1989 Feb; 99(2):151-7. PubMed ID: 2783615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological status of septic and trauma patients. II. Proliferative response and production of interleukin 6 and tumor necrosis factor alpha by peripheral blood mononuclear cells from septic survivor, nonsurvivor and trauma patients: a correlation with the survival rate.
    Adamik B; Zimecki M; Właszczyk A; Kübler A
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):277-84. PubMed ID: 9523001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of hemorrhagic serum on interleukin-2 generation and utilization.
    Abraham E; Tanaka T; Chang YH
    Crit Care Med; 1988 Apr; 16(4):307-11. PubMed ID: 3258221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-2 production by cord blood lymphocytes stimulated with mitogen and in the mixed leukocyte culture.
    Hauser GJ; Zakuth V; Rosenberg H; Bino T; Spirer Z
    J Clin Lab Immunol; 1985 Jan; 16(1):37-40. PubMed ID: 3156997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there correlation of T cell proliferative functions and surface marker phenotypes in patients with acquired immune deficiency syndrome or lymphadenopathy syndrome?
    Gluckman JC; Klatzmann D; Cavaille-Coll M; Brisson E; Messiah A; Lachiver D; Rozenbaum W
    Clin Exp Immunol; 1985 Apr; 60(1):8-16. PubMed ID: 3924452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radio-immunological study of the regulation of interleukin-2 production in peripheral blood mononuclear cell cultures from normal subjects and rheumatoid arthritis patients.
    Bernier J; Reuter A; Vrindts-Gevaert Y; Gathy-Meuleman R; Frere MC; Franchimont P
    Clin Exp Rheumatol; 1989; 7(1):35-41. PubMed ID: 2785012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-2 production and response to exogenous interleukin-2 in a patient with the acquired immune deficiency syndrome (AIDS).
    Hauser GJ; Bino T; Rosenberg H; Zakuth V; Geller E; Spirer Z
    Clin Exp Immunol; 1984 Apr; 56(1):14-7. PubMed ID: 6609030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin 2 (IL 2) and cancer. In vitro response to exogenous R and non-R IL 2 by PHA-activated and non-PHA-activated PBMC from patients with cancer.
    Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
    J Exp Pathol; 1987; 3(4):539-47. PubMed ID: 3502651
    [No Abstract]   [Full Text] [Related]  

  • 34. Impaired T cell proliferation in acute dengue infection.
    Mathew A; Kurane I; Green S; Vaughn DW; Kalayanarooj S; Suntayakorn S; Ennis FA; Rothman AL
    J Immunol; 1999 May; 162(9):5609-15. PubMed ID: 10228044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory effects of cytokines and cyclosporine A on peripheral blood mononuclear cells from stable multiple sclerosis patients.
    Guillen C; Prieto A; Alvarez-Cermeño JC; de la Piedra M; Gimeno A; Alvarez-Mon M
    Immunopharmacol Immunotoxicol; 1999 Aug; 21(3):527-49. PubMed ID: 10466078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of interleukin 1 and interleukin 2 production by patients with advanced cancer.
    Dawood FA; Moreira SS; Dancona C; Shimizu LT
    Braz J Med Biol Res; 1989; 22(10):1259-70. PubMed ID: 2638197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of IL-6 level in human peripheral blood mononuclear cells stimulated with PHA/LPS after occupational exposure to chromium.
    Katiyar S; Awasthi SK; Sahu RK
    Sci Total Environ; 2008 Feb; 390(2-3):355-61. PubMed ID: 18031794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic and functional analysis of peripheral blood mononuclear cells in generalised aggressive and chronic periodontitis patients.
    Emingil G; Karaarslan F; Keskinoğlu A; Coker I; Atilla G
    J Int Acad Periodontol; 2001 Oct; 3(4):87-94. PubMed ID: 12666947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A monoclonal antibody inhibiting leucocyte adhesion blocks induction of IL-2 production but not IL-2 receptor expression.
    Lindqvist C; Patarroyo M; Beatty PG; Wigzell H
    Immunology; 1987 Apr; 60(4):579-84. PubMed ID: 3108139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
    Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.